About Technology Issues FAQ

Links

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO) — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.